Bill > S08285

This bill requires manufacturers of kratom products in New York to include specific warning labels on their packaging starting January 1, 2026. The bill defines kratom as a tree native to Southeast Asia and its derived herbal supplements, and mandates that each package must display a warning in at least 12-point type stating that the product has not been approved by the FDA and listing potential side effects, including nausea, agitation, hallucinations, breathing difficulties, liver damage, and potential death. Additionally, the legislation prohibits manufacturers from advertising or packaging kratom products as "all natural," which the bill defines as products containing no artificial ingredients or added colors and minimally processed. Manufacturers who violate these requirements will face civil penalties of up to $500 for a first violation and up to $1,000 for subsequent violations. The bill aims to increase consumer awareness about the potential risks associated with kratom products and prevent potentially misleading marketing claims. The legislation will take effect one year after becoming law.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/S8285